臓器特異的遺伝子発現制御を目的とした組織押圧核酸導入法の開発

スポンサーリンク

概要

• 論文の詳細を見る

•   A mechanism-based logical approach is a mainstream of current novel drug therapy development in the context of these trends and, therefore, the elucidation of gene function and the molecular level mechanism analysis of diseases at an individual level in mammals are essential in addition to that in cultured cells. In vivo gene transfection techniques are also indispensable for these purposes as well as the evaluation of gene therapy and nucleic acid-based therapy approaches and clinical applications during the process of development of novel drug therapies. Various recombinant virus and synthetic carrier-mediated transfection methods have been reported, however, above all, naked plasmid DNA transfection without virus vectors, synthetic carriers and special physical devices has attracted much attention, because of its advantages including convenience of preparation and handling and lack of toxicity associated with the transfection agents. In this review, I collect the information of these naked plasmid DNA transfection methods involving tissue pressure-mediated transfection from the comprehensive view point including side effects. Additively, the key physiological phenomena affecting transgene expression, especially activation of transcriptional factors, are reviewed. Combined with conventional approach based with biodistribution control, regulation of physiological change in transfected cells will provide spatial- and temporal-controlled transgene expression at various organs, which leads us to elucidate mechanism of diseases and to develop novel drug therapy in near future.

著者

• 向井 英史

  京都大学大学院薬学研究科薬品動態制御学分野

関連論文

• 腎臓への核酸導入技術の開発(誌上シンポジウム)
• 肺への遺伝子デリバリー
• メカニカルマッサージによる肝臓選択的遺伝子導入法の開発
• 遺伝子治療・核酸医薬品開発におけるDDS技術(誌上シンポジウム)
• 臓器特異的遺伝子発現制御を目的とした組織押圧核酸導入法の開発

スポンサーリンク